Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) IPO
IPO
Priced at US$19.00 a share on Jan 29, 2020.
- Price
- US$19.00 a share
- Shares offered
- 10,586,316 shares of common stock
- Offering size
- US$201.1 million
- Underwriters' option
- Up to 1,587,947 more shares
- Underwriters
- J.P. Morgan, Jefferies, Cowen, Canaccord Genuity · In the order on the cover
- Shares delivered
- On or about Feb 3, 2020
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Aug 23, 2019 |
| Filed publicly | Jan 3, 2020 |
| Amended once | Jan 21, 2020 |
| Shares registered with an exchange | Jan 27, 2020 |
| Declared effective by the SEC | Jan 29, 2020 |
| Final prospectus, with the price | Jan 30, 2020 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jan 30, 2020 |
| EFFECT · Notice that a registration is effective | Jan 29, 2020 |
| S-1MEF · Registration of more shares for the same offering | Jan 29, 2020 |
| CERT · Exchange's certificate of listing | Jan 29, 2020 |
| 8-A12B · Registration of shares for listing on an exchange | Jan 27, 2020 |
| CORRESP · Letter to the SEC | Jan 27, 2020 |
| CORRESP · Letter to the SEC | Jan 27, 2020 |
| CORRESP · Letter to the SEC | Jan 21, 2020 |
| S-1/A · Registration statement, amended | Jan 21, 2020 |
| CORRESP · Letter to the SEC | Jan 13, 2020 |
| UPLOAD · Letter from the SEC | Jan 10, 2020 |
| S-1 · Registration statement | Jan 3, 2020 |
| DRS/A · Draft registration statement, amended | Dec 13, 2019 |
| DRSLTR · Letter to the SEC with a draft | Oct 30, 2019 |
| DRS/A · Draft registration statement, amended | Oct 30, 2019 |
| UPLOAD · Letter from the SEC | Oct 17, 2019 |
| DRSLTR · Letter to the SEC with a draft | Oct 7, 2019 |
| DRS/A · Draft registration statement, amended | Oct 7, 2019 |
| UPLOAD · Letter from the SEC | Sep 19, 2019 |
| DRS · Draft registration statement | Aug 23, 2019 |
From the cover of the final prospectus (424B4) filed Jan 30, 2020